Abstract
The observation that doxycycline and other tetracyclines reduced the level of matrix metalloproteinase (MMP) activity in periodontal disease, even in germ-free rats [1 2] prompted the testing of these compounds for treatment of osteoarthritis (OA) [3 4], rheumatoid arthritis (for extensive review of this topic see [5-9]) and other diseases in which MMP-mediated destruction of connective tissues is prominent, such as abdominal aortic aneurysms [10] and wound healing in diabetes [11]. Doxycycline and chemically modified tetracyclines have been tested in animal models of OA, a disease in which the degradation of joint connective tissues is thought to depend, at least partially, on MMP activity. In our laboratory, we have employed doxycycline to treat canine experimental OA. We have examined the effect of treatment with oral doxycycline on the MMP of tissues from patients with rheumatoid arthritis, see [5-9], and patients with OA at the time of joint replacement surgery [3]. Similar studies have been performed using minocycline for treatment of adjuvant arthritis in rats [12], and for chemically modified tetracycline-7 (cmt-7) in a spontaneous model of OA in Taft-Hartley guinea pigs [13]. The guinea pig model resembles human disease in that the development of OA is weight-and age-dependent. Treatment with doxycycline slowed disease progression in the animal models, while MMP activity was reduced in both animal and human tissues.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Golub LM, Lee HM, Lehrer G, Nemiroff A, McNamara TF, Kaplan R, Ramamurthy NS (1983) Minocycline reduces gingival collagenolytic activity during diabetes. Preliminary observations and a proposed new mechanism of action. J Periodont Res 18: 516–526
Greenwald RA, Golub LM, Lavietes B, Ramamurthy NS, Gruber B, Laskin RS, McNamara TF (1987) Tetracyclines inhibit human synovial collagenase in vivo and in vitro. J Rheumatol 14: 28–32
Smith GN Jr, Yu LP Jr, Brandt KD, Capello WN (1998) Oral administration of doxycycline reduces collagenase and gelatinase activities in extracts of human osteoarthritic cartilage. J Rheumatol 25: 532–535
Smith GN Jr, Mickler EA, Hasty KA, Brandt KD (1999) Specificity of inhibition of matrix metalloproteinase activity by doxycycline: Relationship to structure of the enzyme. Arthritis Rheum 42: 1140–1146
Alarcon GS (2000) Tetracyclines for the treatment of rheumatoid arthritis. Expert Opin Investig Drugs 9: 1491–1498
Langevitz P, Livenah A, Bank I, Pras M (2000) Benefits and risks of minocycline in rheumatoid arthritis. Drug Safety 22: 405–414
Alarcon GS, Bartolucci AA (2000) Radiographic assessment of disease progression in rheumatoid arthritis patients treated with methotrexate or minocycline. J Rheumatol 27: 530–534
Eichenfield AH (1999) Minocycline and autoimmunity. Curr Opin Pediatr 11: 447–456
O’Dell JR, Paulsen G, Haire CE, Blakely K, Palmer W, Wees S, Eckhoff PJ, Klassen LW, Churchill M, Doud D et al (1999) Treatment of early seropositive rheumatoid arthritis with minocycline: four-year followup of a double-blind, placebo-controlled trial. Arthritis Rheum 42: 1691–1695
Curci JA, Mao D, Bohner DG, Allen BT, Rubin BG, Reilly JM, Sicard GA, Thompson RW (2000) Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metalloproteinases in patients with abdominal aortic aneurysms. J Vasc Surg 31: 325–342
Ramamurthy NS, Kucine AJ, McClain SA, McNamara TF, Golub LM (1998) Topically applied CMT-2 enhances wound healing in streptozotocin diabetic rat skin. Adv Dent Res 12: 144–148
Zernicke RF, Wohl GR, Greenwald RA, Moak SA, Leng W, Golub LM (1997) Administration of systemic matrix metalloproteinase inhibitors maintains bone mechanical integrity in adjuvant arthritis. J Rheumatol 24: 1324–1331
de Bri E, Lei W, Svensson O, Chowdhury M, Moak SA, Greenwald RA (1998) Effect of an inhibitor of matrix metalloproteinases on spontaneous osteoarthritis in guinea pigs. Adv Dent Res 12: 82–85
Yu LP Jr, Smith GN Jr, Brandt KD, Myers SL, O’Connor BL, Brandt DA (1992) Reduction of the severity of canine osteoarthritis by prophylactic treatment with oral doxycycline. Arthritis Rheum 35: 1150–1159
Yu LP Jr, Smith GN Jr, Brandt KD, O’Connor BL, Myers SL (1993) Therapeutic administration of doxycycline slows the progression of cartilage destruction in canine osteoarthritis. Trans Orthop Res Soc 18: 724
Cole AA, Chubinskaya S, Luchene Li, Chlebek K, Orth MW, Greenwald RA, Kuettner KE, Schmid TM (1994) Doxycycline disrupts chondrocyte differentiation and inhibits cartilage matrix degradation. Arthritis Rheum 37: 1727–1734
Cole AA, Chubinskaya S, Chlebek K, Orth MW, Luchene LL, Schmid TM (1994) Doxycycline inhibition of cartilage matrix degradation. Ann NYAcad Sci 732: 414–415
Arsenis C, Moak SA, Greenwald RA (1992) Tetracyclines (TETs) inhibit the synthesis and/or activity of cartilage proteinases in vivo and in vitro. Matrix Suppl 11: 314
Curci JA, Petrinec D, Liao S, Golub LM, Thompson RW (1998) Pharmacologic suppression of experimental abdominal aortic aneurysms: a comparison of doxycycline and four chemically modified tetracyclines. J Vasc Surg 28: 1082–1093
Ryan ME, Ramamurthy NS, Sorsa T, Golub LM (1999) MMP-mediated events in diabetes. Ann NYAcad Sci 878: 311–334
Rifkin BR, Vernillo AT, Golub LM (1993) Blocking periodontal disease progression by inhibiting tissue-destructive enzymes: a potential therapeutic role for tetracyclines and their chemically-modified analogs. J Periodontol 64 (8 Suppl): 819–827
Sasaki T, Kaneko H, Ramamurthy NS, Golub LM (1991) Tetracycline administration restores osteoblast structure and function during experimental diabetes. Anat Rec 231: 25–34
Golub LM, McNamara TF, D’Angelo G, Greenwald RA, Ramamurthy NS (1987) A non-antibacterial chemically-modified tetracycline inhibits mammalian collagenase activity. J Dent Res 66: 1310–1314
Golub LM, Lee HM, Ryan ME, Giannobile WV, Payne J, Sorsa T (1998) Tetracyclines inhibit con-nective tissue breakdown by multiple non-antimicrobial mechanisms. Adv Dent Res 12: 12–26
Burns FR, Stack MS, Gray RD, Paterson CA (1989) Inhibition of purified collagenase from alkali-burned rabbit corneas. Invest Ophthalmol Visual Sci 30: 1569–1575
Ryan ME, Greenwald RA, Golub LM (1996) Potential of tetracyclines to modify cartilage breakdown in osteoarthritis. Curr Opin Rheumatol 8: 238–247
Suomalainen K, Sorsa T, Ingman T, Lindy O, Golub LM (1992) Tetracycline inhibition identifies the cellular origin of interstitial collagenases in human periodontal diseases in vivo. Oral Microbiol Immunol 7: 121–123
Smith GN Jr, Brandt KD, Hasty KA (1996) Activation of recombinant human neutrophil procollagenase in the presence of doxycycline results in fragmentation of the enzyme and loss of enzyme activity. Arthritis Rheum 39: 235–244
Yu LP Jr, Smith GN Jr, Hasty KA, Brandt KD (1991) Doxycycline inhibits type XI collagenolytic activity in human osteoarthritic cartilage and of gelatinase. J Rheumatol 18: 1450–1452
Nip LH, Uitto V-J, Golub LM (1993) Inhibition of epithelial cell matrix metalloproteinases by tetracyclines. J Periodont Res 28: 379–385
Greenwald RA, Golub LM, Ramamurthy NS, Chowdhury M, Moak SA, Sorsa T (1998) In vitro sensitivity of the three mammalian collagenases to tetracycline inhibition: relationship to bone and cartilage degradation. Bone 22: 33–38
Smith GN Jr, Brandt KD, Hasty KA (1994) Procollagenase is reduced to inactive fragments upon activation in the presence of doxycycline. Ann NYAcad Sci 732: 436–438
Amin AR, Attur MG, Thakker GD, Patel PD, Vyas PR, Patel RN, Patel IR, Abramson SB (1996) A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. Proc Natl Acad Sci USA 93: 14014–14 0149
Cillari E, Milano S, D’Agostino P, Di Bella G, La Rosa M, Barbera C, Ferlazzo V, Cammarata G, Grimaudo S, Tolomeo M et al (1998) Modulation of nitric oxide production by tetracyclines and chemically modified tetracyclines. Adv Dent Res 12: 126–130
D’Agostino P, Arcoleo F, Barbera C, Di Bella G, La Rosa M, Misiano G, Milano S, Brai M, Cammarata G et al (1998) Tetracycline inhibits the nitric oxide synthase activity induced by endotoxin in cultured murine macrophages. Eur J Pharmacol 346: 283–290
Vernillo AT, Rifkin BR (1998) Effects of tetracyclines on bone metabolism. Adv Dent Res 12: 56–62
Yrjanheikki J, Tikka T, Keinanen R, Goldsteins G, Chan PH, Koistinaho J (1999) A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci USA 96: 13 496–13 500
Yrjanheikki J, Keinanen R, Pellikka M, Hokfelt T, Koistinaho J (1998) Tetracyclines inhibit microglical activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci USA 95: 15 769–15 774
Weingart JD, Sipos EP, Brem H (1995) The role of minocycline in the treatment of intracranial 9L glioma. J Neurosurg 82: 635–640
Clark WM (1997) Cytokines and reperfusion injury. Neurology 49 (Suppl 4): S10–4
Yamaki K, Yoshida N, Kimura T, Ohbayashi H, Takagi K (1998) Effects of cytokines and minocycline on subacute lung injuries induced by repeated injection of lipopolysaccharide. Kansenshogaku Zasshi 72: 75–82
Jonat C, Chung FZ, Baragi VM (1996) Transcriptional downregulation of stromelysin by tetracy cline. J Cell Bloch 60: 341–347
Hanemaaijer R, Visser H, Koolwijk P, Sorsa T, Salo T, Golub LM, van Hinsbergh VW (1998) Inhibition of MMP synthesis by doxycycline and chemically modified tetracyclines (CMTs) in human endothelial cells. Adv Dent Res 12: 114–118
Mengshol JA, Vincenti MP, Coon CI, Barchowsky A, Brinckerhoff CE (2000) Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappaB: differential regulation of collagenase 1 and collagenase 3. Arthritis Rheum 43: 801–811
Vincenti MP, Coon CI, Brinckerhoff CE (1998) Nuclear factor kappaB/p50 activates an element in the distal matrix metalloproteinase 1 promoter in interleukin-lbeta-stimulated synovial fibroblasts. Arthritis Rheum 41: 1987–1994
Vincenti MP, Coon CI, Lee O, Brinckerhoff CE (1994) Regulation of collagenase gene expression by IL-1 beta requires transcriptional and post-transcriptional mechanisms. Nucleic Acids Res 22: 4818–4827
Shlopov BV, Lie WR, Mainardi CL, Cole AA, Chubinskaya S, Hasty KA (1997) Osteoarthritic lesions: involvement of three different collagenases. Arthritis Rheum 40: 2065–2074
Shlopov BV, Stuart JM, Gumanovskaya ML, Hasty KA (2001) Regulation of cartilage collagenase by doxycycline. J Rheumatol 28: 835–842
Shlopov BV, Smith GN Jr, Cole AA, Hasty KA (1999) Differential response patterns to doxycycline and tat in down-regulation of collagenases in osteoarthritic and normal human chondrocytes. Arthritis Rheum 42: 719–727
Craig RG, Yu Z, Xu L, Barr R, Ramamurthy N, Boland J, Schneir M, Golub LM (1998) A chemically modified tetracycline inhibits streptozotocin-induced diabetic depression of skin collagen synthesis and steady-state type I procollagen mRNA. Biochim Biophys Acta 1402: 250–260
Schneir M, Ramamurthy N, Golub L (1990) Minocycline-treatment of diabetic rats normalizes skin collagen production and mass: possible causative mechanisms. Matrix 10: 112–123
Sasaki T, Ramamurthy NS, Yu Z, Golub LM (1992) Tetracycline administration increases protein (presumably procollagen) synthesis and secretion in periodontal ligament fibroblasts of streptozotocin-induced diabetic rats. J Periodont Res 27: 631–639
Davies SR, Cole AA, Schmid TM (1996) Doxycycline inhibits type X collagen synthesis in avian hypertrophic chondrocyte cultures. J Biol Chem 271: 25 966–25 970
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Basel AG
About this chapter
Cite this chapter
Gerald, N., Smith, J., Hasty, K.A. (2001). Structure/function studies of doxycycline effects on matrix metalloproteinase activity and cartilage degeneration. In: Nelson, M., Hillen, W., Greenwald, R.A. (eds) Tetracyclines in Biology, Chemistry and Medicine. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8306-1_12
Download citation
DOI: https://doi.org/10.1007/978-3-0348-8306-1_12
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-9511-8
Online ISBN: 978-3-0348-8306-1
eBook Packages: Springer Book Archive